Physician profile
Glenn R Singer
NPI 1831174499
$15,365.37
in general payments reported to CMS, 2019-2025
53 companies · $3,579 in 2025
The $3,579 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,395 · 2020: $1,722 · 2021: $1,448 · 2022: $1,804 · 2023: $2,425 · 2024: $1,993 · 2025: $3,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,537 · Education: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,536.94 |
| Education | $459.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,259.17 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $2,063.42 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Actelion Pharmaceuticals US, INC. | $1,735.94 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Insmed, INC. | $921.04 | 2019-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $820.65 | 2020-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $774.15 | 2019-2025 | Jascayd, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $709.24 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $478.31 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $467.37 | 2019-2024 | Yupelri, Yupelri |
| Jazz Pharmaceuticals INC. | $351.54 | 2021-2025 | Xywav |
| United Therapeutics Corporation | $342.52 | 2021-2025 | Tyvaso |
| Inspire Medical Systems, INC. | $290.55 | 2024-2025 | Inspire |
| Amgen INC. | $270.99 | 2019-2025 | Tezspire |
| Lilly USA, LLC | $266.90 | 2023-2025 | Zepbound, Mounjaro |
| Sunovion Pharmaceuticals INC. | $258.78 | 2019-2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $246.11 | 2025 | Yupelri |
| Pfizer INC. | $232.15 | 2019-2025 | |
| Genzyme Corporation | $230.13 | 2021-2025 | |
| Axsome Therapeutics, INC. | $208.05 | 2023-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $198.02 | 2020-2023 | Glassia |
| Boston Scientific Corporation | $183.37 | 2019-2022 | |
| Zoll Respicardia, INC. | $176.97 | 2023 | Remede System |
| Verona Pharma, INC. | $176.66 | 2025 | Ohtuvayre |
| Fisher & Paykel Healthcare INC | $162.86 | 2023-2025 | Fisher & Paykel Healthcare |
| Radius Health, INC. | $122.33 | 2020-2023 | Tymlos |
| Pulmonx Corporation | $121.51 | 2022-2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Baxter Healthcare | $110.65 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Mallinckrodt Hospital Products INC. | $99.95 | 2025 | Acthar |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.56 | 2019-2024 | Xifaxan |
| Ani Pharmaceuticals, INC. | $97.33 | 2024-2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $94.35 | 2019-2021 | |
| Philips North America LLC | $75.37 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $70.12 | 2022-2025 | |
| Electromed, INC. | $58.74 | 2019-2025 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $53.65 | 2021 | |
| Merck Sharp & Dohme LLC | $50.22 | 2024-2025 | Winrevair, Keytruda |
| Genentech, INC. | $49.95 | 2021 | |
| Circassia INC. | $48.56 | 2019-2020 | |
| Esperion Therapeutics, INC. | $39.48 | 2024-2025 | Nexletol |
| Novo Nordisk INC | $35.85 | 2022-2023 | Wegovy |
| Avadel Cns Pharmaceuticals, LLC | $32.58 | 2023-2024 | Lumryz |
| Advanced Respiratory, INC | $29.97 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $29.25 | 2021 | |
| Exact Sciences Corporation | $28.16 | 2023 | Cologuard Collection Kit |
| Csl Behring | $27.30 | 2020 | |
| Sumitomo Pharma America, INC. | $26.73 | 2025 | Gemtesa |
| Resmed Corp | $26.33 | 2025 | |
| Liquidia Technologies, INC. | $24.53 | 2025 | Yutrepia |
| Bayer Healthcare Pharmaceuticals INC. | $22.22 | 2025 | |
| Shire North American Group INC | $19.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.38 | 2021 | |
| Astellas Pharma US INC | $17.34 | 2020 | |
| Itamar Medical INC | $12.88 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.